Close
| |

Home Page

Company Database

Licensing Deals

Investors

Latest updates

25 May 2015
Updates within the latest 30 days:

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next
Reset 

Phase III Clinical Data Show Zebinix® (Eslicarbazepine Acetate) to Be Effective and Well Tolerated in Elderly

HATFIELD, England, May 26, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 26 May 2015
Related companies:  Eisai China Inc. | Eisai Co. Ltd.

Concordia Healthcare Announces Changes to the Board of Directors, Management Team and Auditors

TORONTO, May 25, 2015 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced several key changes to the Company's board of directors (the... Read more ››

By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Concordia Healthcare Corp.

The Princess Margaret Cancer Foundation Launches A New Awareness-building Marketing Campaign

At the Princess Margaret Cancer Centre, "Why" is in Our DNA

Read more ››
By: PR Newswire Association LLC. - 25 May 2015
Related companies:  University Health Network - Princess Margaret Cancer Centre

Strengthening health research in Quebec - SUPPORT Unit builds foundation for patient-oriented research

MONTREAL, May 25, 2015 /CNW Telbec/ - Jacques Gourde, Member of Parliament for Lotbinière-Chutes-de-la-Chaudière, on behalf of Canada's Health Minister Rona Ambrose, and Quebec Health Minister Gaétan Barrette were joined by Dr. Alain Beaudet, President of the Canadian Institutes of Health... Read more ››

By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Canadian Institutes of Health Research | Canadian Institutes of Health Research  

A scientific breakthrough helps explain how DNA is organized in our cells

The discovery by IRCM researchers could lead to a better understanding of lymphoma

Read more ››
By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Institut de recherches cliniques de Montréal (IRCM)

Amorfix Announces Financial Results for First Quarter 2015

TSX: AMF

Read more ››
By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Amorfix Life Sciences Ltd.

Prince Edward Island funds treatment with AUBAGIO(TM) for Relapsing Remitting Multiple Sclerosis

Once-daily oral medication to be reimbursed for first-line use

Read more ››
By: PR Newswire Association LLC. - 25 May 2015

Governments and others urged to join forces as Canada's first ever Rare Disease Strategy released

OTTAWA, May 25, 2015 /CNW/ - Today, on Parliament Hill, the Canadian Organization for Rare Disorders (CORD) released Canada's Rare Disease Strategy and called upon the federal, provincial and territorial governments along researchers, healthcare providers, educators, employers, and the patient... Read more ››

By: PR Newswire Association LLC. - 25 May 2015

Mylan/Perrigo Clarification

HERTSFORDSHIRE, England, May 25, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules (the "Rules"), relating to its firm intention to make an... Read more ››

By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Mylan (UK)

CRN Emphasizes Importance of Iodine this World Thyroid Day

WASHINGTON, May 25, 2015 /PRNewswire-USNewswire/ -- As part of efforts to increase awareness of thyroid health on today's 8(th) Annual World Thyroid Day, the Council for Responsible Nutrition (CRN) joins the American Thyroid Association (ATA) and its sister international thyroid societies in... Read more ››

By: PR Newswire Association LLC. - 25 May 2015

Biotie announces agreement with FDA on a Special Protocol Assessment for tozadenant Phase 3 study

Read more ››
By: Nasdaq / GlobenewsWire - 25 May 2015
Related companies:  Biotie Therapies AG | Biotie Therapies Corp.

Pharming and Cytobioteck Announce Distribution Agreement for Ruconest

LEIDEN, The Netherlands, May 25, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 25 May 2015
Related companies:  Pharming Group NV | Valeant Pharmaceuticals International, Inc.

EU Falsified Medicines Directive; Aegate Highlights Belgium as the Real Benchmark

CAMBRIDGE, England, May 24, 2015 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 24 May 2015

Arrhythmias Therapeutic (Cardiovascular) Pipeline Review H1 2015 Research Report

DALLAS, May 24, 2015 /PRNewswire-iReach/ -- The report "Arrhythmias - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development... Read more ››

By: PR Newswire Association LLC. - 24 May 2015

WHA reaches agreement on polio, International Health Regulations and strengthening surgical care

GENEVA, 22 May 2015 / PRN Africa / -- GENEVA-The World Health Assembly continued progress Friday, reaching agreements on polio eradication; further implementation of the International Health Regulations (2005); surgical care and medical products.

Read more ››
By: PR Newswire Association LLC. - 23 May 2015

Physicians Advocacy Institute ("PAI") Endorses the Fair Medical Audit Acts of 2015

WASHINGTON, May 22, 2015 /PRNewswire/ -- Today, U.S. Representative George Holding of North Carolina introduced "The Fair Medical Audits Act of 2015." The Physician Advocacy Institute ("PAI") strongly endorses this legislation, which would address fundamental concerns that physicians have with... Read more ››

By: PR Newswire Association LLC. - 23 May 2015

Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research

CHAPEL HILL, N.C., May 22, 2015 /PRNewswire/ -- Research and Benchmarking firm, Best Practices, LLC will be hosting its sixth Medical Affairs Roundtable on Thursday,... Read more ››

By: PR Newswire Association LLC. - 23 May 2015

Statement from Minister Ambrose on Thalidomide

OTTAWA, May 22, 2015 /CNW/ - More than fifty years ago, Thalidomide was approved by Health Canada and prescribed to treat morning sickness in expectant mothers. Tragically, Thalidomide caused serious and permanent physical and emotional damage to mothers, children and families.

Read more ››
By: PR Newswire Association LLC. - 22 May 2015

Official Statement from the Thalidomide Survivors Taskforce concerning Health Canada's Program to Assist the Canada's 94 Living Victims of Thalidomide

TORONTO, May 22 2015 /CNW/ - The Taskforce representing Canada's living victims of Thalidomide are very appreciative of all the hard work that the Minister and Health Canada have put into this program over the past six months. This program recognizes the needs of the thalidomide survivors, and... Read more ››

By: PR Newswire Association LLC. - 22 May 2015

Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR

DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014 preliminary injunction requiring the Company to continue distribution of NAMENDA(®) (memantine HCl)... Read more ››

By: PR Newswire Association LLC. - 22 May 2015
Related companies:  Actavis plc
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 - Next